Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis

Identification of Chronic Active Multiple Sclerosis Lesions on 3T MRI

(2018) M. Absinta et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM

(2018) Kofi Deh et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

(2018) Raju Kapoor et al.   LANCET NEUROLOGY

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study

(2018) David H. Miller et al.   Annals of Clinical and Translational Neurology

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

(2018) Jerry S. Wolinsky et al.   ANNALS OF NEUROLOGY

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

(2018) Colm Elliott et al.   Multiple Sclerosis Journal

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

(2017) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

(2017) Xavier Montalban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging

(2016) Assunta Dal-Bianco et al.   ACTA NEUROPATHOLOGICA

Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions

(2016) Martina Absinta et al.   JOURNAL OF CLINICAL INVESTIGATION

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

(2016) Fred Lublin et al.   LANCET

The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis

(2016) Diego Cadavid et al.   Multiple Sclerosis Journal

Advanced MRI and staging of multiple sclerosis lesions

(2016) Martina Absinta et al.   Nature Reviews Neurology

The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis

(2016) Diego Cadavid et al.   Multiple Sclerosis Journal

Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque

(2015) Josa M. Frischer et al.   ANNALS OF NEUROLOGY

Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study

(2015) Charles RG Guttmann et al.   Multiple Sclerosis Journal

Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study

(2015) Charles RG Guttmann et al.   Multiple Sclerosis Journal

Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis

(2013) Kunio Nakamura et al.   NeuroImage-Clinical

Association between pathological and MRI findings in multiple sclerosis

(2012) Massimo Filippi et al.   LANCET NEUROLOGY

Demyelination versus remyelination in progressive multiple sclerosis

(2010) Stephan Bramow et al.   BRAIN

The relation between inflammation and neurodegeneration in multiple sclerosis brains

(2009) Josa M. Frischer et al.   BRAIN

The search for responsive clinical endpoints in primary progressive multiple sclerosis

(2009) LVAE Bosma et al.   Multiple Sclerosis Journal

Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

(2008) Zhaleh Khaleeli et al.   ANNALS OF NEUROLOGY